233 related articles for article (PubMed ID: 31492829)
21. Hypercalcemia of Malignancy in a Dog Diagnosed With Cholangiocellular Carcinoma.
Martínez-Sogues L; Vila A; Roura X; Pastor J; Novellas R; Marco A; Cuvertoret-Sanz M; Martínez J; Solano-Gallego L
Top Companion Anim Med; 2019 Jun; 35():1-5. PubMed ID: 31122681
[TBL] [Abstract][Full Text] [Related]
22. Zoledronate-responsive calcitriol-mediated hypercalcemia in a 5-year-old case with squamous cell carcinoma on the background of xeroderma pigmentosum.
Colak U; Mutlu GY; Sozmen BO; Yucel EB; Kayserili H; Hatun S
J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1403-1406. PubMed ID: 31782950
[TBL] [Abstract][Full Text] [Related]
23. The emerging role of denosumab in the long-term management of parathyroid carcinoma-related refractory hypercalcemia.
Fountas A; Andrikoula M; Giotaki Z; Limniati C; Tsakiridou E; Tigas S; Tsatsoulis A
Endocr Pract; 2015 May; 21(5):468-73. PubMed ID: 25667369
[TBL] [Abstract][Full Text] [Related]
24. Detection of parathyroid hormone-related protein in cats with humoral hypercalcemia of malignancy.
Bolliger AP; Graham PA; Richard V; Rosol TJ; Nachreiner RF; Refsal KR
Vet Clin Pathol; 2002; 31(1):3-8. PubMed ID: 12019470
[TBL] [Abstract][Full Text] [Related]
25. Recurrent distal cholangiocarcinoma and humoral hypercalcemia of malignancy: report of a rare case and literature review.
Ito J; Sakai K; Yamamoto Y; Nakajima R; Ito K; Fujii M; Matsumura H; Takayashiki N; Kurata M; Inagawa S; Yagyu H
Endocr J; 2023 Apr; 70(4):375-384. PubMed ID: 36543188
[TBL] [Abstract][Full Text] [Related]
26. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM).
Kobayashi N; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Tomimoto A; Yoneda K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A; Yamanaka S; Inayama Y
J Hepatobiliary Pancreat Surg; 2008; 15(5):531-5. PubMed ID: 18836809
[TBL] [Abstract][Full Text] [Related]
27. Use of denosumab to treat refractory hypercalcemia in a peritoneal dialysis patient with immobilization and tertiary hyperparathyroidism.
Pratt RM; West ML; Tennankore KK
Perit Dial Int; 2020 Jan; 40(1):103-106. PubMed ID: 32063140
[TBL] [Abstract][Full Text] [Related]
28. [Penile carcinoma with humoral hypercalcemia of malignancy (HHM): a case report].
Sekita N; Furuya Y; Ueda T; Okano T; Ito H; Matsuzaki O
Hinyokika Kiyo; 1999 Jul; 45(7):497-9. PubMed ID: 10466069
[TBL] [Abstract][Full Text] [Related]
29. Denosumab for the treatment of bisphosphonate resistant hypercalcemia in a hemodialysis patient.
Dahmani O; Sophoclis C; Kebir M; Bouguern D; Sakho A; Demarchi P
Saudi J Kidney Dis Transpl; 2017; 28(1):154-157. PubMed ID: 28098117
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
31. Incidence of humoral hypercalcemia of malignancy among hypercalcemic patients with cancer.
Szymanski JJ; Otrock ZK; Patel KK; Scott MG
Clin Chim Acta; 2016 Jan; 453():190-3. PubMed ID: 26706788
[TBL] [Abstract][Full Text] [Related]
32. [Denosumab normalized plasma calcium concentration in malignancy-associated hypercalcaemia].
Størling L; Villadsen GE; Krogh K; Vestergaard P
Ugeskr Laeger; 2014 Jul; 176(30):. PubMed ID: 25292242
[TBL] [Abstract][Full Text] [Related]
33. Denosumab for management of parathyroid carcinoma-mediated hypercalcemia.
Vellanki P; Lange K; Elaraj D; Kopp PA; El Muayed M
J Clin Endocrinol Metab; 2014 Feb; 99(2):387-90. PubMed ID: 24178790
[TBL] [Abstract][Full Text] [Related]
34. [Malignancy-associated hypercalcemia].
Yamaguchi K
Gan To Kagaku Ryoho; 1991 Mar; 18(3):343-9. PubMed ID: 2003737
[TBL] [Abstract][Full Text] [Related]
35. Expression of parathyroid hormone-related protein mRNA in tumors obtained from patients with humoral hypercalcemia of malignancy.
Honda S; Yamaguchi K; Suzuki M; Sato Y; Adachi I; Kimura S; Abe K
Jpn J Cancer Res; 1988 Jun; 79(6):677-81. PubMed ID: 3137193
[TBL] [Abstract][Full Text] [Related]
36. Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with zoledronic acid and Denosumab.
Kilci F; Demirsoy U; Jones JH; Çakır Ö; Çizmecioğlu-Jones FM
J Pediatr Endocrinol Metab; 2022 Aug; 35(8):1107-1112. PubMed ID: 35534911
[TBL] [Abstract][Full Text] [Related]
37. Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism.
Zhang P; Yu Y; Gao Y; Yuan G; Zhang J; Wang W
Hemodial Int; 2023 Apr; 27(2):E23-E28. PubMed ID: 36719850
[TBL] [Abstract][Full Text] [Related]
38. Humoral hypercalcemia of malignancy in squamous cell carcinoma of the skin: parathyroid hormone--related protein as a cause.
Cisneros G; Lara LF; Crock R; Whittier FC
South Med J; 2001 Mar; 94(3):329-31. PubMed ID: 11284521
[TBL] [Abstract][Full Text] [Related]
39. Hypercalcemia of Malignancy.
Hu MI
Endocrinol Metab Clin North Am; 2021 Dec; 50(4):721-728. PubMed ID: 34774243
[TBL] [Abstract][Full Text] [Related]
40. A Case of Fibroblast Growth Factor Receptor Fusion-Positive Intrahepatic Cholangiocarcinoma With Humoral Hypercalcemia of Malignancy.
Chauhan A; Likasitwatanakul P; Ahmed A; Sibley SD
Cureus; 2024 Apr; 16(4):e58741. PubMed ID: 38779292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]